Y. Lynn Wang

5.4k total citations
116 papers, 3.5k citations indexed

About

Y. Lynn Wang is a scholar working on Genetics, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Y. Lynn Wang has authored 116 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Genetics, 46 papers in Molecular Biology and 35 papers in Pathology and Forensic Medicine. Recurrent topics in Y. Lynn Wang's work include Chronic Lymphocytic Leukemia Research (36 papers), Lymphoma Diagnosis and Treatment (32 papers) and Chronic Myeloid Leukemia Treatments (15 papers). Y. Lynn Wang is often cited by papers focused on Chronic Lymphocytic Leukemia Research (36 papers), Lymphoma Diagnosis and Treatment (32 papers) and Chronic Myeloid Leukemia Treatments (15 papers). Y. Lynn Wang collaborates with scholars based in United States, China and United Kingdom. Y. Lynn Wang's co-authors include Ailin Guo, Morton Coleman, Nicholas C.P. Cross, Pin Lu, Jiao Ma, Michael Rosbash, Amy V. Jones, Richard T. Silver, Shuhua Cheng and Valérie Goguel and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

Y. Lynn Wang

106 papers receiving 3.4k citations

Peers

Countries citing papers authored by Y. Lynn Wang

Since Specialization

Citations

This map shows the geographic impact of Y. Lynn Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Lynn Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Lynn Wang more than expected).

Fields of papers citing papers by Y. Lynn Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. Lynn Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Lynn Wang. The network helps show where Y. Lynn Wang may publish in the future.

Co-authorship network of co-authors of Y. Lynn Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Y. Lynn Wang. A scholar is included among the top collaborators of Y. Lynn Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. Lynn Wang. Y. Lynn Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Negatively Charged Carbon Dot‐Linked Glycyrrhizic Acid Hydrogel Promoted Hemostasis, Immunoregulation and Re‐Epithelialization of Wound Closure 2026 ·Small ·(unknown), Hao Wang, (unknown), (unknown), Y. Lynn Wang, (unknown), (unknown), (unknown), (unknown), (unknown)	0
2	Development, validation, and clinical application of a machine learning model for risk stratification and management of cervical cancer screening based on full-genotyping hrHPV test (SMART-HPV): a modelling study 2025 ·The Lancet Regional Health - Western Pacific ·Binhua Dong, Zhen Lü, Tianjie Yang, Junfeng Wang, Yan Zhang, (unknown), Juntao Wang, (unknown), (unknown), Cheng Huan, Xiaoli Cao, Xinxin Huang, Zheng Zheng, (unknown), Y. Lynn Wang, Huifeng Xue, (unknown), (unknown), Huachun Zou, (unknown)	5
3	Recurrent Melanoma in a Patient with Chronic Lymphocytic Leukemia (CLL) Presenting with an Apparent Co-Existing NRAS and BRAF Mutation: A Diagnostic and Treatment Conundrum 2025 ·International Journal of Molecular Sciences ·(unknown), (unknown), Y. Lynn Wang, Anthony J. Olszanski	0
4	Acute myeloid leukemia with a novel AKAP9::PDGFRA fusion transformed from essential thrombocythemia: A case report and mini review 2024 ·Leukemia Research Reports ·Yavuz Şahin, Jianming Pei, Don A. Baldwin, (unknown), (unknown), (unknown), Y. Lynn Wang, Reza Nejati, Joseph R. Testa	0
5	In-design DFM pattern optimization with ML models for dynamic fixing guidance selection and implementation 2024 ·(unknown), (unknown), J. K. Nelson, Y. Lynn Wang, (unknown)	0
6	Progressive pseudorheumatoid dysplasia involving a novel CCN6 mutation: a case report 2024 ·Frontiers in Immunology ·Yu Li, Zhengping Huang, Yan Yun, Feng Guo, Gang Wei, Y. Lynn Wang, Yu Xie	0
7	Validation of a Molecular Diagnostic Test for Circulating Tumor DNA by Next-Gen Sequencing 2023 ·International Journal of Molecular Sciences ·Sandra V. Fernandez, (unknown), Shilpa Rao, (unknown), Fathima Sheriff, Hossein Borghaei, Efrat Dotan, (unknown), Martin J. Edelman, Joseph Treat, Julia Judd, R. Katherine Alpaugh, Y. Lynn Wang, Jian Yu, Mariusz A. Wasik, Don A. Baldwin	2
8	Multiple Genomic Alterations, Including a Novel AFF4::IRF1 Fusion Gene, in a Treatment-Refractory Blastic Plasmacytoid Dendritic-Cell Neoplasm: A Case Report and Literature Review 2023 ·International Journal of Molecular Sciences ·Yavuz Şahin, Y. Lynn Wang, Jianming Pei, (unknown), Michael Styler, Joseph R. Testa, Reza Nejati	3
9	Nanomaterials Modulating the Fate of Dental-Derived Mesenchymal Stem Cells Involved in Oral Tissue Reconstruction: A Systematic Review 2023 ·International Journal of Nanomedicine ·(unknown), Y. Lynn Wang, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	6
10	Isochromosome 7p, i(7)(p10): A rare AML, myelodysplasia-related entity 2023 ·Leukemia Research Reports ·Reza Nejati, (unknown), Zemin Liu, (unknown), (unknown), Jianming Pei, Y. Lynn Wang, Joseph R. Testa	0
11	Leukemic presentation and progressive genomic alterations of MCD/C5 diffuse large B-cell lymphoma (DLBCL) 2023 ·Molecular Case Studies ·(unknown), Reza Nejati, Pin Lu, (unknown), (unknown), (unknown), (unknown), Don A. Baldwin, Jianming Pei, Sandeep S. Davé, Y. Lynn Wang, Mariusz A. Wasik	3
12	Concordance between four PD-L1 immunohistochemical assays and 22C3 pharmDx assay in esophageal squamous cell carcinoma in a multicenter study 2023 ·SHILAP Revista de lepidopterología ·Liyan Xue, Yuan Li, Lili Jiang, Chao Liu, (unknown), Changyuan Guo, Yan Jin, Ping Zhou, Xuemin Xue, Y. Lynn Wang, Weiya Wang, Yanhui Liu, Jianming Ying	0
13	Prognostic and Predictive Molecular Biomarkers in Chronic Lymphocytic Leukemia 2020 ·Journal of Molecular Diagnostics ·Jimmy Lee, Y. Lynn Wang	20
14	XPO1 Inhibitor Selinexor Overcomes Intrinsic Ibrutinib Resistance in Mantle Cell Lymphoma via Nuclear Retention of IκB 2018 ·Molecular Cancer Therapeutics ·Mei Ming, Wenjun Wu, Bingqing Xie, Madina Sukhanova, Weige Wang, Sabah Kadri, Shruti Sharma, Jimmy Lee, Sharon Shacham, Yosef Landesman, Natalia Maltsev, Pin Lu, Y. Lynn Wang	36
15	Cerdulatinib Pharmacodynamics and Relationships to Tumor Response Following Oral Dosing in Patients with Relapsed/Refractory B-cell Malignancies 2018 ·Clinical Cancer Research ·Greg Coffey, Jiajia Feng, (unknown), Anjali Pandey, (unknown), Janet M. Leeds, (unknown), Sabah Kadri, Pin Lu, Jeremy P. Segal, Y. Lynn Wang, Glenn Michelson, John T. Curnutte, Pamela B. Conley	29
16	XPO1 Inhibitor Selinexor Overcomes Ibrutinib Resistance in Mantle Cell Lymphoma Via Nuclear Retention of IκB 2017 ·Blood ·Y. Lynn Wang, Mei Ming, Bingqing Xie, Madina Sukhanova, Weige Wang, Sabah Kadri, Shruti Sharma, Jimmy Lee, Sharon Shacham, Yosef Landesman, Natalia Maltsev, Pin Lu	1
17	Clinical Validation of a Next-Generation Sequencing Genomic Oncology Panel via Cross-Platform Benchmarking against Established Amplicon Sequencing Assays 2016 ·Journal of Molecular Diagnostics ·Sabah Kadri, Bradley Long, (unknown), Chao Jie Zhen, (unknown), Shruti Sharma, (unknown), Nifang Niu, Sonia Benhamed, Jigyasa H. Tuteja, Tanguy Y. Seiwert, Kevin P. White, Megan E. McNerney, Carrie Fitzpatrick, Y. Lynn Wang, Larissa V. Furtado, Jeremy P. Segal	106
18	Targeting the Hsp90-associated viral oncoproteome in gammaherpesvirus-associated malignancies 2013 ·Blood ·Utthara Nayar, Pin Lü, Rebecca Goldstein, Jelena Vider, Gianna Ballon, Anna Rodina, Tony Taldone, Hediye Erdjument‐Bromage, (unknown), Ronald Blasberg, Ari Melnick, Leandro Cerchietti, Gabriela Chiosis, Y. Lynn Wang, Ethel Cesarman	54
19	Peroxisome Proliferator-Activated Receptor γ Promotes Lymphocyte Survival through Its Actions on Cellular Metabolic Activities 2006 ·The Journal of Immunology ·Seung‐Hee Jo, Chunyan Yang, Qi Miao, Michał Marzec, Mariusz A. Wasik, Pin Lu, Y. Lynn Wang	31
20	Inhibition of Type I Collagen mRNA Expression Independent of Tryptophan Depletion in Interferon-γ-Treated Human Dermal Fibroblasts 1995 ·Journal of Investigative Dermatology ·Tatyana Yufit, (unknown), Raymond R. Brown, John Varga, Y. Lynn Wang	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact